News

Expand filters

Filters

Services

Showing 1 - 5 out of 5 results

Patient Story

Nicole Needed an Innovative Alzheimer's Treatment. Missouri Baptist Sullivan Hospital Made It Easier for Her to Access.

On a recent Wednesday morning, Nicole Bodey sat with a smile beneath a warm blanket in the Cancer and Infusion Center at Missouri Baptist Sullivan Hospital. Her husband of 57 years, Bud Bodey, sat by her side, as he always does after driving Nicole from their Springfield, Missouri, home to the hospital for her newly approved innovative infusion treatment for early stage Alzheimer’s disease.

Article

Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.

Patient Story

Restoring Hope: How a Breakthrough Treatment Helped a Teenager Defeat Epilepsy

Sophia suffered from epilepsy that for years disrupted her life and put severe limitations on her future. But after receiving a groundbreaking procedure from the pediatric neurology team at St. Louis Children’s Hospital, Sophia, now 18, is seizure free.

Article

Helping Your Knees Age

What’s the most common health concern for people over 65?

Article

Diabetes and the COVID-19 Vaccine: What you need to know

Now that three COVID-19 vaccines have been authorized for use, questions are circulating about the vaccines’ safety and effectiveness, and if and when those with certain health conditions, such as diabetes, should get vaccinated.